Table 2 Patient characteristics by obesity class or metabolic syndrome status
| Â | Metabolic Syndrome Status | Obesity Class | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
HFpEF with Metabolic Syndrome | HFpEF without Metabolic Syndrome | HFpEF with Class 1 Obesity | HFpEF with Class 2 Obesity | HFpEF with Class 3 Obesity | ||||||
N = 138,824 | N = 125,747 | N = 147,433 | N = 117,138 | N = 138,824 | ||||||
Age (median, IQR) | 74 | (66–80) | 80 | (68–80) | 75 | (67–80) | 72 | (65–80) | 68 | (60–75) |
Age Group (N,%) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 18–64 | 29,324 | 21.1% | 24,396 | 19.4% | 11,690 | 19.1% | 9633 | 24.5% | 18,146 | 38.7% |
 65–79 | 53,081 | 38.2% | 33,251 | 26.4% | 21,400 | 35.0% | 15,909 | 40.4% | 19,575 | 41.7% |
 80+ | 56,419 | 40.6% | 68,100 | 54.2% | 28,092 | 45.9% | 13,793 | 35.1% | 9195 | 19.6% |
Sex, Female (N,%) | 74,053 | 53.3% | 66,446 | 52.8% | 29,741 | 48.6% | 22,287 | 56.7% | 33,120 | 70.6% |
Race/Ethnicity (N,%) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Non-Hispanic White | 80,873 | 58.3% | 76,895 | 61.2% | 36,739 | 60.0% | 23,034 | 58.6% | 25,254 | 53.8% |
 Non-Hispanic Black | 12,653 | 9.1% | 7828 | 6.2% | 4327 | 7.1% | 3624 | 9.2% | 6424 | 13.7% |
 Hispanic | 6754 | 4.9% | 4898 | 3.9% | 2869 | 4.7% | 1732 | 4.4% | 1804 | 3.8% |
 Other/Unknown | 38,544 | 27.8% | 36,126 | 28.7% | 17,247 | 28.2% | 10,945 | 27.8% | 13,434 | 28.6% |
BMI (mean, SD) | 36.0 | 7.8 | 29.2 | 7.5 | 32.3 | 1.4 | 37.3 | 1.4 | 46.5 | 5.3 |
Metabolic Syndrome Components (N,%) | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Diabetes | 89,628 | 64.6% | 7781 | 6.2% | 23,903 | 39.1% | 17,648 | 44.9% | 23,084 | 49.2% |
 Dyslipidemia | 128,257 | 92.4% | 60,745 | 48.3% | 45,585 | 74.5% | 28,553 | 72.6% | 31,209 | 66.5% |
 Hypertension | 137,087 | 98.7% | 99,406 | 79.1% | 55,281 | 90.4% | 36,003 | 91.5% | 42,764 | 91.2% |
 Obesity | 112,547 | 81.1% | 34,886 | 27.7% | 61,182 | 100% | 39,335 | 100% | 46,916 | 100% |